Relmada Therapeutics Inc
NASDAQ:RLMD
Relmada Therapeutics Inc
NASDAQ:RLMD
Price:
5.35
USD
4.09%
Market Closed
Market Cap:
$561.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Relmada Therapeutics Inc
NASDAQ:RLMD
|
US |
|
Community Health Systems Inc
NYSE:CYH
|
US |
|
C
|
China Literature Ltd
OTC:CHLLF
|
CN |
|
I
|
Ingersoll Rand Inc
SWB:5GD
|
US |
|
Saab AB
LSE:0GWL
|
SE |
|
A
|
Arch Resources Inc
F:ACCA
|
US |
|
TD Synnex Corp
NYSE:SNX
|
US |
|
AJ Bell PLC
F:3FY
|
UK |
|
PennyMac Mortgage Investment Trust
NYSE:PMT
|
US |
|
L
|
Loews Corp
DUS:LTR
|
US |
|
Nikon Corp
TSE:7731
|
JP |
|
Z
|
Zalando SE
WSE:ZAL
|
DE |
Multiples-Based Value
The Multiples-Based Value for Relmada Therapeutics Inc (RLMD) under the Base Case is hidden
USD.
Compared with the current market price of 5.35 USD, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
RLMD Multiples-Based Value
LOCKED
